Skip to main content
. 2019 Sep 6;1(2):dlz042. doi: 10.1093/jacamr/dlz042

Figure 4.

Figure 4.

Rationalization options for pathogen-directed treatment of Gram-negative bacteria. Susceptibility tests for all listed antimicrobials were not performed for all isolates; therefore there is no consistent denominator for each antimicrobial. Results are shown for 35 bacterial isolates recovered from infections where meropenem therapy was continued and not rationalized following positive microbiology.